CN101062949A - 重组抗人IgE单克隆抗体及其制备方法和用途 - Google Patents
重组抗人IgE单克隆抗体及其制备方法和用途 Download PDFInfo
- Publication number
- CN101062949A CN101062949A CN 200710101487 CN200710101487A CN101062949A CN 101062949 A CN101062949 A CN 101062949A CN 200710101487 CN200710101487 CN 200710101487 CN 200710101487 A CN200710101487 A CN 200710101487A CN 101062949 A CN101062949 A CN 101062949A
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- variable region
- expression vector
- ige
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
细胞株编号 | 1A3 | 2B5 | 4C6 | 9B3 | 5E6 | 6F2 | 8G1 | 8H5 | 6B2 | 8E3 | 5H3 | 7D2 | 5F2 |
表达量(微克/毫升) | 165.4 | 152.6 | 152.9 | 286.4 | 168.9 | 153.8 | 302.3 | 251.4 | 233.1 | 152.9 | 273.2 | 146.8 | 139.3 |
样品浓度(μg/ml) | 加入rh anti-IgE mAb后释放组胺浓度(ng/ml) | ||
孔1 | 孔2 | 均数 | |
500.0050.005.000.500.05培养液IgE | 12.213.146.864.376.2 | 13.413.742.369.572.9 | 12.813.444.666.974.6 |
样品浓度(μg/ml) | 加入Xolair后释放组胺浓度(ng/ml) | ||
孔1 | 孔2 | 均数 | |
2500.00250.0025.002.50.25培养液IgE | 11.313.243.568.673.310.974.5 | 12.511.740.170.175.411.278.3 | 11.912.541.869.474.411.176.4 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101014872A CN101062949B (zh) | 2006-04-26 | 2007-04-23 | 重组抗人IgE单克隆抗体及其制备方法和用途 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610026068.2 | 2006-04-26 | ||
CN200610026068 | 2006-04-26 | ||
CN2007101014872A CN101062949B (zh) | 2006-04-26 | 2007-04-23 | 重组抗人IgE单克隆抗体及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101062949A true CN101062949A (zh) | 2007-10-31 |
CN101062949B CN101062949B (zh) | 2011-07-27 |
Family
ID=38964256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101014872A Withdrawn - After Issue CN101062949B (zh) | 2006-04-26 | 2007-04-23 | 重组抗人IgE单克隆抗体及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101062949B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101230103B (zh) * | 2008-03-25 | 2011-09-07 | 中国医药集团总公司四川抗菌素工业研究所 | 一全人源重组抗-IgE抗体 |
CN102399289A (zh) * | 2011-10-21 | 2012-04-04 | 复旦大学 | 一种人源抗人IgE的抗体Fab片段、编码基因及用途 |
CN102660569A (zh) * | 2012-04-21 | 2012-09-12 | 大连理工大学 | 一种重组人IgE受体蛋白的制备方法及应用 |
CN107635584A (zh) * | 2015-04-09 | 2018-01-26 | 康奈尔大学 | 基因治疗以预防对过敏原的反应 |
CN108341878A (zh) * | 2018-02-07 | 2018-07-31 | 上海蓝怡科技股份有限公司 | 一种鼠抗人IgE单克隆抗体及其制备方法和应用 |
CN111875706A (zh) * | 2020-07-16 | 2020-11-03 | 广州康盛生物科技股份有限公司 | 一种抗人IgE蛋白的单域抗体及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994511A (en) * | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
GB9908533D0 (en) * | 1999-04-14 | 1999-06-09 | Novartis Ag | Organic compounds |
-
2007
- 2007-04-23 CN CN2007101014872A patent/CN101062949B/zh not_active Withdrawn - After Issue
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101230103B (zh) * | 2008-03-25 | 2011-09-07 | 中国医药集团总公司四川抗菌素工业研究所 | 一全人源重组抗-IgE抗体 |
CN102399289A (zh) * | 2011-10-21 | 2012-04-04 | 复旦大学 | 一种人源抗人IgE的抗体Fab片段、编码基因及用途 |
CN102660569A (zh) * | 2012-04-21 | 2012-09-12 | 大连理工大学 | 一种重组人IgE受体蛋白的制备方法及应用 |
CN102660569B (zh) * | 2012-04-21 | 2013-11-06 | 大连理工大学 | 一种重组人IgE受体蛋白的制备方法及应用 |
CN107635584A (zh) * | 2015-04-09 | 2018-01-26 | 康奈尔大学 | 基因治疗以预防对过敏原的反应 |
CN108341878A (zh) * | 2018-02-07 | 2018-07-31 | 上海蓝怡科技股份有限公司 | 一种鼠抗人IgE单克隆抗体及其制备方法和应用 |
CN111875706A (zh) * | 2020-07-16 | 2020-11-03 | 广州康盛生物科技股份有限公司 | 一种抗人IgE蛋白的单域抗体及其应用 |
CN111875706B (zh) * | 2020-07-16 | 2021-03-30 | 广州康盛生物科技股份有限公司 | 一种抗人IgE蛋白的单域抗体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101062949B (zh) | 2011-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1678744A (zh) | 人的抗人白细胞介素-6抗体以及所述抗体的片段 | |
CN1771338A (zh) | 高亲和力抗人类IgE抗体 | |
CN105348390B (zh) | 抗人pcsk9单克隆抗体 | |
CN1443199A (zh) | 人mcp-1的抗体 | |
CN1033290A (zh) | 用同源重组技术生产嵌合抗体 | |
CN101062949A (zh) | 重组抗人IgE单克隆抗体及其制备方法和用途 | |
CN101074264A (zh) | 一种重组抗ctla4单克隆抗体及其制备方法和用途 | |
US20070141047A1 (en) | Feline immunoglobulin e proteins and compositions thereof | |
CN1681926A (zh) | 人的抗人mcp-1抗体和该抗体的片段 | |
CN1328605A (zh) | 重组细胞的制备方法 | |
CN1541266A (zh) | 用于治疗过敏症及哮喘病的Fcε融合蛋白 | |
WO2022093640A1 (en) | Anti-nkg2c agents and compositions and methods for making and using the same | |
CN1844150A (zh) | 可溶性人cd28分子检测试剂盒及其应用 | |
CN1966526A (zh) | 一种进化免疫球蛋白结合分子、其制备方法及应用 | |
CN1911963A (zh) | Sars中和性抗体及应用 | |
CN1296385C (zh) | 抗猪生长激素单克隆抗体及制备方法及应用 | |
CN1175958A (zh) | 单克隆抗独特型抗体(ab2)和其用途 | |
CN112795543B (zh) | 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用 | |
CN1305904C (zh) | 人源的抗破伤风毒素单克隆抗体的制备和应用 | |
CN1524957A (zh) | 重组蛋白a基因及其表达产物的制备与应用 | |
CN1189484C (zh) | 重组抗人CD11a单克隆抗体及其制法和药物组合物 | |
CN101074263A (zh) | 一种重组抗proteinA单克隆抗体及其制备方法和用途 | |
CN1873005A (zh) | 蚯蚓微管结合蛋白Tau、其编码基因及其应用 | |
CN101074265A (zh) | 一种重组抗tnfr单克隆抗体及其制备方法和用途 | |
CN1286726A (zh) | 组胺及血清素结合分子 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080801 Address after: Shanghai City, Pudong New Area Jing Road No. 351 Building No. 1 room 431 Applicant after: Shanghai Guojian Biological Technology Institute Address before: Bing Shanghai Road, Pudong New Area Zhangjiang hi tech Park No. 399 Applicant before: Zhongxin Guojian Pharmaceutical Co., Ltd., Shanghai |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO.,LTD. Free format text: FORMER OWNER: SHANGHAI GUOJIAN BIOTECHNOLOGY INSTITUTE Effective date: 20110104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 ROOM 431, BUILDING 1, NO.351, GUOSHOUJING ROAD, PUDONG NEW DISTRICT,SHANGHAI TO: 201203 NO.399, LIBING ROAD, HIGH-TECH PARK, ZHANGJIANG, PUDONG NEW DISTRICT, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110104 Address after: Shanghai city 201203 libing road Pudong New Area Zhangjiang hi tech Park No. 399 Applicant after: Shanghai CP Guojian Pharmaceutical Co., Ltd. Address before: 201203 Shanghai city Pudong New Area Jing Road No. 351 Building No. 1 room 431 Applicant before: Shanghai Guojian Biological Technology Institute |
|
ASS | Succession or assignment of patent right |
Owner name: ANTIBODIES NATIONAL ENGINEERING RESEARCH CENTER Free format text: FORMER OWNER: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO., LTD. Effective date: 20110330 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 NO. 399, LIBING ROAD, ZHANGJIANG HIGH-TECH. PARK, PUDONG NEW DISTRICT, SHANGHAI TO: 201203 BUILDING 3, NO. 399, LIBING ROAD, ZHANGJIANG HIGH-TECH. PARK, PUDONG NEW DISTRICT, SHANGHAI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110330 Address after: Shanghai city 201203 libing road Zhangjiang High Tech Park of Pudong New Area No. 399 building 3 Applicant after: Antibodies National Engineering Research Center Address before: Shanghai city 201203 libing road Pudong New Area Zhangjiang hi tech Park No. 399 Applicant before: Shanghai CP Guojian Pharmaceutical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
AV01 | Patent right actively abandoned |
Granted publication date: 20110727 Effective date of abandoning: 20140321 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |